Gilead Sciences
GILD
#102
Rank
HK$1.460 T
Marketcap
HK$1,178
Share price
-0.52%
Change (1 day)
34.89%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): HK$57.94

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is HK$58.21. In 2025 the company made an earnings per share (EPS) of HK$53.74 an increase over its 2024 EPS that were of HK$2.98.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$57.947.81%
2025HK$53.741702.63%
2024HK$2.98-91.65%
2023HK$35.7023.98%
2022HK$28.79-25.86%
2021HK$38.834850%
2020HK$0.78-97.64%
2019HK$33.260.9%
2018HK$32.9718.71%
2017HK$27.77-64.88%
2016HK$79.08-18.45%
2015HK$96.9755.28%
2014HK$62.45296.02%
2013HK$15.7717.89%
2012HK$13.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.53 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.28-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$16.14-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.44 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.60 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$73.35 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$43.39-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$133.45 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$28.05-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA